Skip to content
Trial Eligibility
Menu

Acceptance and Commitment Therapy for Adolescents and Young Adults With Sickle Cell Disease

NCT05685368

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

The current study seeks to build on previous research that demonstrates the efficacy of Acceptance and Commitment Therapy in combating stigma by investigating the feasibility and acceptability of a protocol to support Black adolescents and young adults in coping with race related stress. The study will consist of a small, purposeful, non-randomized sample (N = 30) of clients enrolled into a 10-session Acceptance and Commitment Therapy group. The group will be offered as part of regular clinical care at the Division of Adolescent and Young Adult Medicine.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Race-related Stress
  • Depression, Anxiety
  • Quality of Life
  • Stress Reaction

Eligibility basics and study details

Study type
Interventional
Phase
Phase 1/2
Ages
14 to 21 years
Sex
All
Healthy volunteers
Not accepted
Sponsor
Children's Hospital Los Angeles
Last updated on ClinicalTrials.gov
May 6, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

California · 1

  • Children's Hospital Los Angeles · Los Angeles, CA

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.